\begin{thebibliography}{10}

\bibitem{got06spe}
Scott Gottlieb.
\newblock Speech before 2006 {Conference on Adaptive Design}.
\newblock \url{http://www.fda.gov/oc/speeches/2006/trialdesign0710.html}, July
  10 2006.

\bibitem{fei77cli}
Alvan~R. Feinstein.
\newblock {\em Clinical Biostatistics}.
\newblock C. V. Mosby, St.\ Louis, 1977.

\bibitem{eme95sto}
Scott~S. Emerson.
\newblock Stopping a clinical trial very early based on unplanned interim
  analysis: {A} group sequential approach.
\newblock {\em Biometrics}, 51:1152--1162, 1995.

\bibitem{spi94bay}
David~J. Spiegelhalter, Laurence~S Freedman, and Mahesh K.~B. Parmar.
\newblock Bayesian approaches to randomized trials.
\newblock {\em J Roy Stat Soc A}, 157:357--416, 1994.

\bibitem{har01usi}
Frank~E. Harrell and Tina Shih.
\newblock Using full probability models to compute probabilities of actual
  interest to decision-makers.
\newblock {\em International Journal of Technology Assessment in Health Care},
  17:17--26, 2001.

\bibitem{ber06bay}
Donald~A. Berry.
\newblock Bayesian clinical trials.
\newblock {\em Nat Rev}, 5:27--36, 2006.
\newblock Editorial, p.\ 3.

\bibitem{emeiss}
Scott~S. Emerson.
\newblock Issues in the use of adaptive clinical trial designs.
\newblock {\em Stat Med}, 25:3270--3296, 2006.

\bibitem{ber04acc}
Scott~M. Berry and Donald~A. Berry.
\newblock Accounting for multiplicities in assessing drug safety: {A}
  three-level hierarchical mixture model.
\newblock {\em Biometrics}, 60:418--426, 2004.

\bibitem{bugs2}
W.~R. Gilks, A.~Thomas, and D.~J. Spiegelhalter.
\newblock A language and program for complex {Bayesian} modeling.
\newblock {\em The Statistician}, 43:169--177, 1994.
\newblock \url{http://www.mrc-bsu.cam.ac.uk/bugs}.

\bibitem{R}
{R Development Core Team}.
\newblock {\em R: A language and environment for statistical computing}.
\newblock R Foundation for Statistical Computing, Vienna, Austria, 2005.
\newblock {ISBN} 3-900051-07-0, \url{http://www.R-project.org}.

\end{thebibliography}
